Recent studies looked at prevalence of diagnosed diabetes in the U.S.; trends in hospitalization for diabetic ketoacidosis; and the prevalence of obesity, metabolic syndrome, and diabetes.
Several recent studies addressed the effects of diabetes and diabetes treatments on cardiovascular risk.
The risks of cancer in patients taking medication for diabetes were analyzed by 2 recent studies.
Recent studies looked at how often patients underuse insulin due to cost, whether Supplemental Nutrition Assistance Program participation reduces cost-related nonadherence, and how high deductibles affect the timing of care for macrovascular
Two papers published in the past month compared human and analog insulins, while another looked at the advantages and disadvantages of inhaled insulin.
Recent studies looked at diabetic retinopathy's associations with age-related macular degeneration, chronic kidney disease, and different classes of diabetes drugs.
Some beneficial effects of rosiglitazone and pioglitazone were described by studies published in the last month.
Recent studies examined potential associations of the drugs with heart failure, pancreatic cancer, and fractures.
Recent studies looked at biomarkers to predict diabetes, characteristics of patients who developed type 1 diabetes during adulthood, and use of oral insulin to try to prevent type 1 diabetes.
Recent industry-funded studies compared degludec, an ultralong-acting, once-daily basal insulin, to basal insulin glargine on outcomes including hypoglycemia, glucose control, and cardiovascular events.